Reasons may be less biological benefit of the heterozygous IL10RA variants compared to the Sickle cell disease causing hemoglobin variants that confer selective advantage in the malaria setting and higher mortality of IL10RA variants in the homozygous state. The gene discussed is IL10RA; the disease is malaria.